Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO GI 2021 | ASCO GI 2021: highlighting progress in rare cancers

Gayathri Anandappa • 22 Jan 2021
ASCO GI 2021
Bile Duct Cancer Gastrointestinal Cancer Liver Cancer Pancreatic Cancer

Gayathri Anandappa, MBBS, MRCP, MPhil, The Royal Marsden NHS Foundation Trust, London, UK, discusses highlights from the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, touching on progress in patients with rare cancers such as cholangiocarcinoma and hepatocellular carcinoma, as well as the importance of developing novel approaches for patients with pancreatic cancers. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Gayathri Anandappa

4:00
Personalizing the approach to CRC
Gayathri Anandappa • 22 Jan 2021
6:58
Personalizing ctDNA analysis to predict CRC relapse
Gayathri Anandappa • 22 Jan 2021

Related Videos

0:52
DRP-104 with durvalumab in fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
1:06
The emerging role of cancer vaccines in treating liver cancer
Marina Baretti • 9 Apr 2024
1:33
Peptide vaccines with ICIs for fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
The content of VJOncology is intended for healthcare professionals